drugset
Drugs / Trimethoprim/sulfamethoxazole
last change Jan 2020 re-read 2 minutes ago

Trimethoprim/sulfamethoxazole

Developed for
bacterial infectious disease
Investigated by
Andalusian Public Foundation for Health Research in Seville · Spanish Network for Research in Infectious Diseases

Trials 1 · a red edge is where a trial was stopped

today NCT02795949 · Ph 3
2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02795949 Oct 2016 → Jan 2020 bacterial infectious disease Andalusian Public Foundation for Health Research in Seville Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Trimethoprim/sulfamethoxazole “Trimethoprim/sulfamethoxazole 160/800 mg IV/8 -12h” NCT02795949 ↗
Route Intravenous “Trimethoprim/sulfamethoxazole 160/800 mg IV/8 -12h” NCT02795949 ↗